Table: Daiichi -2022/23 div forecast
Table: Daiichi - 6-MTH parent results
Table: Daiichi - 6-MTH parent results
2022/23 6-month group forecast
Table: Daiichi - Q1 parent results
Table: Daiichi -2021/22 parent results
Seagen down after arbitrator rules in favor of Daiichi in tech ownership dispute
Table: Daiichi - 9-MTH parent results
Table: Daiichi - Q1 parent results
Table: Daiichi -2020/21 parent results
Table: Daiichi - 6-MTH parent results
Table: Daiichi - Q1 parent results
Table: Daiichi -2020/21 parent results
Table: Daiichi -2020/21 div forecast
Table: Daiichi - 9-MTH parent results
Table: Daiichi - 6-MTH parent results
Table: Daiichi - Q1 parent results
AstraZeneca, Daiichi's breast cancer drug gets broader U.S. approval (updated)
Table: Daiichi -2019/20 parent results